Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion type Assertion NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_head.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion evidence source_evidence_literature NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion SIO_000772 24569456 NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion wasDerivedFrom befree-2016 NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion wasGeneratedBy ECO_0000203 NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.